Explore the full record of transactions filed by Iwicki Mark T, Director. Officer active across 2 companies, notably Akero Therapeutics, Inc.. Aggregated, 9 filings have been published. Total volume traded: €184k. The latest transaction was disclosed on 27 June 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Iwicki Mark T is the Chief Executive Officer of Akero Therapeutics, Inc. and Kala Pharmaceuticals, Inc. He leads the strategic and operational activities of these companies, focusing on innovation and growth. With a strong background in the pharmaceutical sector, he is responsible for formulating business strategies and overseeing the executive teams. His leadership is essential for achieving the company’s objectives and ensuring value creation for shareholders.